Jump to content

Consumer & Prescriber Grant Program

Add links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Usernamekiran (AWB) (talk | contribs) at 11:25, 29 January 2023 (checkwiki error, fixed syntax, default sort). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

The Consumer & Prescriber Grant Program (also going by other names, including Attorney General Prescriber Grant Program) was a grant program established with fines paid by Pfizer in the Franklin v. Parke-Davis trial for False Claims Act violations relating to off-label use of gabapentin.[1][2]

Grant recipients

[edit]

There were 24 original grant recipients.

References

[edit]
  1. ^ Rutkow, Lainie; Teret, Stephen (October 2010). "The Potential for State Attorneys General to Promote the Public's Health: Theory, Evidence, and Practice". Robert Wood Johnson Foundation Public Health Law Research Program, via FOLIO.
  2. ^ Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.
  3. ^ "Attorney Generals' Prescriber and Consumer Education Grant". College of Pharmacy. 4 October 2011.
  4. ^ Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.
  5. ^ Elliott, Carl (22 May 2012). "Pharmed Out: an Interview With Adriane Fugh-Berman". The Chronicle of Higher Education Blogs: Brainstorm.
  6. ^ "Federation of State Medical Boards". www.fsmb.org. Archived from the original on 2016-05-20. Retrieved 2017-06-21.
  7. ^ Vermont, University of (14 April 2006). "University Communications : University of Vermont". www.uvm.edu.
  8. ^ Nachbur, Jennifer (May 21, 2013). "Advancing Integrity in Medical Education". www.pewtrusts.org. The Pew Charitable Trusts.
  9. ^ Krautkramer, Christian J. (June 2006). "Neurontin and off-label marketing". AMA Journal of Ethics. 8 (6): 397–402. doi:10.1001/virtualmentor.2006.8.6.hlaw1-0606. PMID 23234671.
[edit]
  • Official website archival copy from March 2011. The website existed from 2008-2011.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Consumer_%26_Prescriber_Grant_Program&oldid=1136238164"